Furthermore, although some studies have suggested a role for NOX1 in gastric, breast, and prostate cancers [71–73], our immunohistochemical evaluation of NOX1 protein revealed that NOX1 was not overexpressed in a large percentage of the tumor specimens we examined with these diagnoses. Here, NOX1 is linked to prostate carcinoma.